• Ceres Becomes Oracle PartnerNetwork Gold Level Partner

    Feb 26, 2015, 00:00 AM by Michael Croft
    THOUSAND OAKS - Feb 26, 2015 - Ceres, Inc. today announced that it has achieved Gold Partner status in Oracle PartnerNetwork. In attaining Gold Level membership, Ceres has been recognized by Oracle for its commitment to establish Oracle-related knowledge in delivering Ceres’ Persephone genome visualization software and for uniquely addressing the challenges of joint customers
    Full story
  • GENALICE RELEASES ITS BREAKTHROUGH DNA DATA ANALYSIS SOLUTION GENALICE MAP ON AMAZON

    Feb 26, 2015, 00:00 AM by Michael Croft
    HARDERWIJK, THE NETHERLANDS - Feb 26, 2015 - Today, biomedical big data solutions company GENALICE announced that they have added a cloud solution via Amazon Web Services (AWS) to its on-premise solution, the GENALICE VAULT
    Full story
  • Kapa Biosystems Launches DNA and RNA Sample Preparation Products at 2015 AGBT Meeting

    Feb 26, 2015, 00:00 AM by Michael Croft
    WILMINGTON, MA - Feb 26, 2015 -
    Kapa Biosystems, Inc. today announced the launch of the latest library preparation products for Next-Generation Sequencing (NGS) DNA and RNA analysis
    Full story
  • 10X Genomics at AGBT

    Feb 25, 2015, 13:55 PM by Michael Croft
    Bio-IT World | On the first day of the annual Advances in Genome Biology & Technology conference in Marco Island, Florida, 10X Genomics has unveiled its GemCode Platform for recovering long-range information from genomes sequenced on Illumina short-read instruments.
    Full story
  • MAVERIX COMPLETE PROVIDES END-TO-END NGS SOLUTION

    Feb 25, 2015, 00:00 AM by Michael Croft
    MARCO ISLAND, FL - Feb 25, 2015 - MARCO ISLAND, FLORIDA - Maverix Biomics Inc. today announced the availability of its Maverix Complete solution at the 16th annual Advances in Genome Biology & Technology (AGBT) meeting in Marco Island, FL
    Full story
  • Allele Frequency Community to Share Data on Population-Wide Incidence of Genetic Variants

    Feb 24, 2015, 12:50 PM by Michael Croft
    Bio-IT World | This morning, diagnostics and laboratory supply company QIAGEN announced the creation of the Allele Frequency Community, a network of academic centers and commercial groups who will share data on the genetic variants they’ve uncovered during human sequencing studies.
    Full story
  • Leading Oncology Researchers Address Growing Need for Assessing Tumor Microenvironment in Cancer Research

    Feb 24, 2015, 00:00 AM by Michael Croft
    MUNICH, GERMANY - Feb 24, 2015 - Key professionals in leading biopharma organizations attended The International Symposium for Tissue Phenomics™ in October 2014 to discuss the latest developments in cancer research and big data
    Full story
  • Rho Highlights Clinical Services Expertise at CALBIO 2015

    Feb 24, 2015, 00:00 AM by Michael Croft
    CHAPEL HILLE, NC, UNITED STATES - Feb 24, 2015 - WHAT:  Rho, a full-service contract research organization (CRO), will highlight its continued success in drug development strategies and services to the California life science industry during the CALBIO 2015 conference, being held March 2-3 in San Francisco
    Full story
  • Foundation Medicine and H3 Biomedicine Sign Oncology Agreement

    Feb 23, 2015, 17:00 PM by Michael Croft
    Bio-IT World | Foundation Medicine and H3 Biomedicine announced a multi-year collaboration today for the discovery and development of precision medicines in oncology. The collaboration marries Foundation Medicine’s comprehensive genomic knowledgebase of more than 35,000 genomic profiles, FoundationCORE, with H3 Biomedicine’s drug discovery engine and computational biology platform.
    Full story
  • Illumina Introduces Automated Library Preparation

    Feb 23, 2015, 09:50 AM by Michael Croft
    Bio-IT World News Brief | This morning, DNA sequencing company Illumina released a new product, NeoPrep, to work alongside its line of next-generation sequencers.
    Full story
  • Networks of Genome Data Will Transform Medicine

    Feb 23, 2015, 00:00 AM by Michael Croft
    MIT Technology Review | 2015's Breakthrough Technologies: A global network of millions of genomes could be medicine's next great advance. Availability: 1-2 years
    Full story
  • BC Platforms excels in genome analyses

    Feb 23, 2015, 00:00 AM by Michael Croft
    ESPOO, FINLAND - Feb 23, 2015 - A recently published methodology paper (Alonso et al, 2015, “GWAS and NGS in bone research”) summarizes the key standard workflows in GWA studies, highlighting essential differences to analyses based on NGS-derived data
    Full story
  • GenomeNext Inks Agreement with Nationwide Children’s Hospital for Genomic Sequencing Analysis

    Feb 23, 2015, 00:00 AM by Michael Croft
    COLUMBUS, OH - Feb 23, 2015 - GenomeNext, LLC, a leader in genomic data management and integrated analysis, announced today an agreement with Nationwide Children’s Hospital under which Nationwide  Children’s will integrate GenomeNext’s genomic sequencing analysis platform for both clinical laboratory services and clinical research initiatives
    Full story
  • Blood Test for Early Cancer Detection

    Feb 22, 2015, 00:00 AM by Michael Croft
    MIT Technology Review | Among Tech Review's top breakthroughs of 2015: liquid biopsy. Fast DNA-sequencing machines are leading to simple blood tests for cancer. Availability: now
    Full story
  • 23andMe Receives FDA Authorization, Will Not Share Test Results

    Feb 20, 2015, 12:00 PM by Michael Croft
    Bio-IT World | The FDA has authorized 23andMe to offer its Bloom syndrome carrier status report to customers, CEO Anne Wojcicki said in an email to customers last night, but the company will not be making the reports available.
    Full story
  • Developing Chemistry Apps in the Cloud

    Feb 20, 2015, 11:00 AM by Michael Croft
    Bio-IT World | Contributed Commentary | The rapid incorporation of touch devices, such as smart phones and tablets, into our personal and business lives increases pressure on software providers to deliver technology via mobile apps. Many tool providers are working to develop mobile versions of existing product that are designed specifically for touch devices. 
    Full story
  • News and Notes from TriCon 2015

    Feb 19, 2015, 12:00 PM by Michael Croft
    Bio-IT World | The Molecular Medicine Tri-Conference is being held in San Francisco this week, and several updates and new products have emerged already. For live coverage of the event, follow @BioITWorld and the hashtag #TriCon on Twitter.
    Full story
  • Playing the Markets: ClusterK Launches Cloud Scheduler, Open Source GATK Pipeline

    Feb 18, 2015, 11:00 AM by Michael Croft
    Bio-IT World | Life is too short to wait for GATK to finish. A new company, ClusterK, is releasing its genomics pipeline to illustrate how complex workflows like the Broad Institute’s GATK can be run efficiently—and much faster—on the cloud thanks to grid scheduling and clever use of Amazon's spot markets.  
    Full story
  • Cenduit Showcases IRT Solutions at Clinical Trial Supply Europe

    Feb 18, 2015, 00:00 AM by Michael Croft
    DURHAM, NC, UNITED STATES - Feb 18, 2015 - WHAT:  Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, is showcasing its solutions and expertise as the largest interactive response technology (IRT) specialist in the world at Clinical Trial Supply Europe, February 25-26 in Cannes, France
    Full story
  • Scientists unveil map of epigenome a second genetic code

    Feb 18, 2015, 00:00 AM by Michael Croft
    Yahoo Finance | Researchers unveiled the map of the "epigenome" in the journal Nature on Wednesday, alongside nearly two dozen related papers. The human genome is the blueprint for building an individual person. The epigenome can be thought of as the cross-outs and underlinings of that blueprint: if someone's genome contains DNA associated with cancer but that DNA is "crossed out" by molecules in the epigenome, for instance, the DNA is unlikely to lead to cancer. As sequencing individuals' genomes to infer the risk of disease becomes more common, it will become all the more important to figure out how the epigenome is influencing that risk as well as other aspects of health.
    Full story